NCT05590637View on ClinicalTrials.gov

Comparing Antipsychotic Medications in LBD Over Time

PHASE4RecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

February 28, 2027

Conditions
Parkinson's Disease PsychosisDementia With Lewy Bodies
Interventions
DRUG

Pimavanserin

Dosage choice and further medication management will be at the discretion of the treating clinician, per routine clinical practice.

DRUG

Quetiapine

Dosage choice and further medication management will be at the discretion of the treating clinician, per routine clinical practice.

Trial Locations (2)

78229

RECRUITING

University Health System, San Antonio

RECRUITING

UT Health Science Center - San Antonio, San Antonio

All Listed Sponsors
collaborator

Alzheimer's Association

OTHER

lead

The University of Texas Health Science Center at San Antonio

OTHER